Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew A Lane

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
Hematology/Oncology Clinics of North America|April 28, 2020
Novel Therapies for Blastic Plasmacytoid Dendritic Cell NeoplasmAndrew A Lane
Clinical Lymphoma, Myeloma & Leukemia|September 1, 2020
Targeting CD123 in AMLAndrew A Lane
Hematology/Oncology Clinics of North America|April 28, 2020
Blastic Plasmacytoid Dendritic Cell Neoplasm in 2020 and BeyondAndrew A Lane
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2009
Histone deacetylase inhibitors in cancer therapyAndrew A Lane, Bruce A Chabner
Cell|November 26, 2003
Neutrophil elastase cleaves PML-RARalpha and is important for the development of acute promyelocytic leukemia in miceAndrew A Lane, Timothy J Ley
Blood|October 5, 2023
DDX41: here, there…and everywhereChristopher R Reilly, Andrew A Lane
Haematologica|March 23, 2023
Tagraxofusp for blastic plasmacytoid dendritic cell neoplasmMarlise R Luskin, Andrew A Lane
Cell|August 10, 2010
Stem cells and DNA damage: persist or perish?Andrew A Lane, David T Scadden
Molecular and Cellular Biology|December 17, 2004
Neutrophil elastase is important for PML-retinoic acid receptor alpha activities in early myeloid cellsAndrew A Lane, Timothy J Ley
The New England Journal of Medicine|February 21, 2019
More on Blastic Plasmacytoid Dendritic-Cell NeoplasmsNaveen Pemmaraju, Marina Konopleva, Andrew A Lane
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Hematology/Oncology Clinics of North America|April 28, 2020
Novel Therapies for Blastic Plasmacytoid Dendritic Cell NeoplasmAndrew A Lane
Clinical Lymphoma, Myeloma & Leukemia|September 1, 2020
Targeting CD123 in AMLAndrew A Lane
Hematology/Oncology Clinics of North America|April 28, 2020
Blastic Plasmacytoid Dendritic Cell Neoplasm in 2020 and BeyondAndrew A Lane
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2009
Histone deacetylase inhibitors in cancer therapyAndrew A Lane, Bruce A Chabner
Cell|November 26, 2003
Neutrophil elastase cleaves PML-RARalpha and is important for the development of acute promyelocytic leukemia in miceAndrew A Lane, Timothy J Ley
Blood|October 5, 2023
DDX41: here, there…and everywhereChristopher R Reilly, Andrew A Lane
Haematologica|March 23, 2023
Tagraxofusp for blastic plasmacytoid dendritic cell neoplasmMarlise R Luskin, Andrew A Lane
Cell|August 10, 2010
Stem cells and DNA damage: persist or perish?Andrew A Lane, David T Scadden
Molecular and Cellular Biology|December 17, 2004
Neutrophil elastase is important for PML-retinoic acid receptor alpha activities in early myeloid cellsAndrew A Lane, Timothy J Ley
The New England Journal of Medicine|February 21, 2019
More on Blastic Plasmacytoid Dendritic-Cell NeoplasmsNaveen Pemmaraju, Marina Konopleva, Andrew A Lane
Pageof 11